Merck v Pfizer: here’s how the two new COVID antiviral drugs work and will be used
Merck v Pfizer: here’s how the two new COVID antiviral drugs work and will be used: Nina Drozdowa/Shutterstock We’ve waited 20 months for a medicine to blunt the coronavirus, and now two have appeared. Earlier this month, the UK medicines regulator approved molnupiravir, the COVID antiviral developed by Merck and Ridgeback Therapeutics. Among adults with …
